
PhD candidate studying tumor immunology/cancer biology in the @balkolab at Vanderbilt University
Joined July 2018
- Tweets109
- Following219
- Followers208
- Likes770
Brandie Taylor retweeted
Please join us in supporting Menghan Mei of the Ren lab as he defends his thesis tomorrow (Thursday, 8/22)!
Brandie Taylor retweeted
Excited to announce that I will be defending my dissertation with the work from @RafatLab and @JulieRhoadesLab! If you are interested in attending, please let me know!
Brandie Taylor retweeted
Komen grantee @BalkoLab presents his work on understanding and improving #breastcancer response to immunotherapy @ #AACR24. To learn more, check out the MBC Impact Series where he discussed his work: bit.ly/4cFtpsN
Brandie Taylor retweeted
So proud of this outstanding scientist and person @BCT255 defending her thesis today. A @SusanGKomen ASPIRE scholar, @CD_AACR @jitcancer published author and all around superstar. Can't wait to see what the future holds!! @VUMCResearch @VUBasicSciences
Today at 2pm in LH214!
I am defending my dissertation next week on March 15th! Grateful for the mentorship by @BalkoLab !
DM me if you would like the zoom link.
Brandie Taylor retweeted
I'm defending next week on March 21st at 11:30 am central time.
Stop by to hear about the secrets of CFTR revealed..
DM me for a zoom link
@Plate_Lab and @MeilerLab
I am defending my dissertation next week on March 15th! Grateful for the mentorship by @BalkoLab !
DM me if you would like the zoom link.
Brandie Taylor retweeted
Congratulations to Cancer Bio student Ebony Hargrove-Wiley & @mvalliance students @_SydneyJamison and Claude Albritton for securing participation in @TheEndoSociety's #FLARE2024 program!
medschool.vanderbilt.edu/bas…
@phdgprotein86 @annetkiraboc1 @Fing1Barb @VanderbiltMPB @VandyPharm
Brandie Taylor retweeted
We had a very productive 9th Annual Early-Career Hill Day. Our 20 AACR Associate Members are wrapping up their meetings, but you can still take action in support of early-career scientists by visiting
bit.ly/48yoSoV. #AACRontheHill #FundNIH
Brandie Taylor retweeted
Today is the AACR Early-Career National Day of Action, and we're calling on early-career scientists, trainees, students, and all who support them to contact members of Congress and ask them to prioritize @NIH funding. Take action: AACR.org/AACRECHD24 #AACRontheHill #FundNIH
Representing Tennessee by spending a day on the Hill to support @NIH funding! Grateful to have met with TN Senators @MarshaBlackburn and @BillHagertyTN. @AACR #AACRonthehill #FundNIH
Brandie Taylor retweeted
Save the date for Vanderbilt Cancer Biology Graduate Program @melissa_m_wolf's (@KimrynRathmell & @JeffRathmell labs) dissertation defense! “VHL Deficiency and the Tumor Microenvironment in Renal Cell Carcinoma”
Friday, March 1st
3:30 PM
PRB 898J
Brandie Taylor retweeted
From the February issue—
#NKG2A is a Therapeutic Vulnerability in #Immunotherapy Resistant MHC-I Heterogeneous Triple Negative #BreastCancer, by @BCT255, @SXPung, @BalkoLab et al.
bit.ly/49CFb4U
@VUMCDiscoveries #TNBC
Brandie Taylor retweeted
Join us in two weeks as Emily Hawes (@EmilyMHawes), a graduate student in the lab of Richard O'Brien, presents her dissertation work on the "Regulation of Glucose-6-Phosphatase Catalytic Subunit 2 (G6PC2) Expression and Activity!"
Brandie Taylor retweeted
A recent paper from the @balkolab, led by Jamaal James and @bct255, indicates that EZH2 inhibition leads to enhanced MHC-II expression potentially through the improvement of chromatin accessibility at CIITA, the master regulator of MHC-II.
doi.org/10.1136/jitc-2023-00…
Brandie Taylor retweeted
Excited to announce our new publication in @SciReports examining the role of talin-1 in macrophages during infectious colitis. Special thanks to our collaborators in the @jeremygoettel lab! We did it @the_yevvy !!🍾🥳 pubmed.ncbi.nlm.nih.gov/3810…
Brandie Taylor retweeted
Congrats @BCT255!!! @SusanGKomen ASPIRE superstar! So proud
Brandie Taylor retweeted
Let’s take a closer look at “Polycomb repressor complex 2 suppresses interferon-responsive MHC-II expression in melanoma cells and is associated with anti-PD-1 resistance” by @BCT255 @BalkoLab at @VUBasicScience @VUMCDiscoveries 1/9
Happy to share our work just out at JITC! We highlight the potential of targeting EZH2 as a therapeutic strategy to enhance MHC-II expression and improve immunotherapy efficacy. @DrJKingJames @BalkoLab
New #JITC article: Polycomb repressor complex 2 suppresses interferon-responsive MHC-II expression in melanoma cells and is associated with anti-PD-1 resistance bit.ly/3QS9Bsf @BCT255 @catherine_fahey @BalkoLab






























